These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 24794183)

  • 21. Autologous cytokine-induced killer cell therapy in lung cancer patients: a retrospective study.
    Zhang J; Zhu L; Du H; He X; Yin Y; Gu Y; Liu L; Lu K; Guo R; Liu P; Shu Y
    Biomed Pharmacother; 2015 Mar; 70():248-52. PubMed ID: 25776508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis.
    Liu Y; Mu Y; Zhang A; Ren S; Wang W; Xie J; Zhang Y; Zhou C
    Onco Targets Ther; 2017; 10():1897-1908. PubMed ID: 28408841
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
    Lee JH; Lee JH; Lim YS; Yeon JE; Song TJ; Yu SJ; Gwak GY; Kim KM; Kim YJ; Lee JW; Yoon JH
    Gastroenterology; 2015 Jun; 148(7):1383-91.e6. PubMed ID: 25747273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment.
    Xie Y; Huang L; Chen L; Lin X; Chen L; Zheng Q
    World J Surg Oncol; 2017 Nov; 15(1):209. PubMed ID: 29179719
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic Cells Therapy with Cytokine-Induced Killer Cells and Activated Cytotoxic T Cells Attenuated Th2 Bias Immune Response.
    Li C; Zhu D; Zhao Y; Guo Q; Sun W; Li L; Gao D; Zhao P
    Immunol Invest; 2020 Jul; 49(5):522-534. PubMed ID: 31793363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combination of chemotherapy and immunotherapy for colon cancer in China: a meta-analysis.
    Wang ZX; Cao JX; Liu ZP; Cui YX; Li CY; Li D; Zhang XY; Liu JL; Li JL
    World J Gastroenterol; 2014 Jan; 20(4):1095-106. PubMed ID: 24574784
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences.
    Ren J; Di L; Song G; Yu J; Jia J; Zhu Y; Yan Y; Jiang H; Liang X; Che L; Zhang J; Wan F; Wang X; Zhou X; Lyerly HK
    Clin Transl Oncol; 2013 Oct; 15(10):780-8. PubMed ID: 23359185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of advanced gastric cancer by chemotherapy combined with autologous cytokine-induced killer cells.
    Jiang J; Xu N; Wu C; Deng H; Lu M; Li M; Xu B; Wu J; Wang R; Xu J; Nilsson-Ehle P
    Anticancer Res; 2006; 26(3B):2237-42. PubMed ID: 16821594
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of dendritic cells co-cultured with cytokine-induced killer cells immunotherapy for non-small-cell lung cancer.
    Wang S; Wang Z
    Int Immunopharmacol; 2015 Sep; 28(1):22-8. PubMed ID: 26013109
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immune modulation and safety profile of adoptive immunotherapy using expanded autologous activated lymphocytes against advanced cancer.
    Sun Z; Shi L; Zhang H; Shao Y; Wang Y; Lin Y; Li X; Bai C
    Clin Immunol; 2011 Jan; 138(1):23-32. PubMed ID: 21041120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIK.
    Wang QJ; Wang H; Pan K; Li YQ; Huang LX; Chen SP; He J; Ke ML; Zhao JJ; Li JJ; Sun JC; Liang XT; Ma HQ; Chen YB; Xia JC
    Chin J Cancer; 2010 Jul; 29(7):641-8. PubMed ID: 20591215
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice.
    Jung NC; Lee JH; Choi HJ; Hwang SU; Song JY; Seo HG; Choi J; Jung SY; Han SG; Lim DS
    Immunol Invest; 2016 Aug; 45(6):553-65. PubMed ID: 27410037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dendritic cells elicit cellular immune response by targeting to capture breast cancer cells].
    Shi YJ; Ren HY; Cen XN; Dong YJ; Ma MX; Zhao YL; Zhu Y; Yu JR
    Zhonghua Zhong Liu Za Zhi; 2008 Feb; 30(2):107-11. PubMed ID: 18646691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect and safety of cytokine-induced killer (CIK) cell immunotherapy in patients with breast cancer: A meta-analysis.
    Hu J; Hu J; Liu X; Hu C; Li M; Han W
    Medicine (Baltimore); 2017 Oct; 96(42):e8310. PubMed ID: 29049237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Maintenance therapy with autologous cytokine-induced killer cells in patients with advanced epithelial ovarian cancer after first-line treatment.
    Liu J; Li H; Cao S; Zhang X; Yu J; Qi J; An X; Yu W; Ren X; Hao X
    J Immunother; 2014; 37(2):115-22. PubMed ID: 24509174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of two different immunotherapies on triple negative breast cancer in animal model.
    Liu X; Hu J; Cao W; Qu H; Wang Y; Ma Z; Li F
    Cell Immunol; 2013; 284(1-2):111-8. PubMed ID: 23973874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Antitumor Immunity and Tumor Responses of Chemotherapy with or without DC-CIK for Non-Small-Cell Lung Cancer in China: A Meta-Analysis of 28 Randomized Controlled Trials.
    Xiao Z; Wang CQ; Zhou MH; Li NN; Sun YP; Wang YZ; Liu SY; Yu HS; Li CW; Zeng XT; Chen L; Yao XS; Feng JH
    J Immunol Res; 2018; 2018():9081938. PubMed ID: 30648123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effect of Achyranthes bidentata polysaccharides stimulated dendritic cells co-cultured with cytokine induced killer cells against SW480 cells].
    Zhou ZD; Xia DJ
    Zhongguo Zhong Yao Za Zhi; 2013 Apr; 38(7):1056-60. PubMed ID: 23847957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy analysis of Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with Paclitaxel-Cisplatin Chemotherapy in patients with Advanced Ovarian Cancer.
    Gao Y; Hao Y; Jia Y
    J BUON; 2021; 26(2):553-560. PubMed ID: 34077005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Dendritic cells reduce the number and function of CD4+CD25+ cells in cytokine-induced killer cells].
    Li H; Ren XB; Zhang P; An XM; Liu H; Hao XS
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(44):3134-8. PubMed ID: 16405818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.